Counselors in Marlborough, CT Accepting Medicare

6 Counselors found. Showing 1 - 6

Mr. Matthew C. Lee, B.S., CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 4 Summer Ln, Marlborough, CT 06447 Phone: 860-841-5068

James A. Govoni, L.P.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 17 Parker Rd, Marlborough, CT 06447 Phone: 860-295-6491

Ms. Jill Bromley, M.S. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 3-5 East Hampton Rd, Unit 5, Marlborough Tavern Green, Marlborough, CT 06447 Phone: 860-778-0560    Fax: 860-365-5318

Dr. Joan Cost Lester, PSY.D., L.P.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 214 Jones Hollow Rd, Marlborough, CT 06447 Phone: 860-295-9565

Mary S. Waszkelewicz, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 187 Jones Hollow Rd, Marlborough, CT 06447 Phone: 860-462-3507

Mrs. Nicolette M Banbury, NCP LPC Counselor Medicare: Medicare Enrolled Practice Location: 11 S Main St, Marlborough, CT 06447 Phone: 860-295-0396    Fax: 860-295-1263

News Archive

Metrohm software products make it easy to comply with ALOCA and ALCOA+ guidelines

Data integrity requires data to be complete, consistent, and accurate throughout their complete lifecycle, providing full transparency and traceability.

Creating ideal neural cells for clinical use

Investigators at the Burnham Institute for Medical Research (Burnham) have developed a protocol to rapidly differentiate human embryonic stem cells (hESCs) into neural progenitor cells that may be ideal for transplantation.

Improper handling of intravenous saline leads to rare bacteria outbreak

Improper handling of intravenous saline at a West Virginia outpatient oncology clinic was linked with the first reported outbreak of Tsukamurella spp., gram-positive bacteria that rarely cause disease in humans, in a new report from the Centers for Disease Control and Prevention (CDC). The report was published in the March issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

EpiCept to receive $0.97M in public offering

EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.

Scientists pinpoint a hidden culprit in heart failure

An international research team led by scientists at the University of Alberta have pinpointed a hidden culprit that leads to dilated cardiomyopathy-a dangerous condition that accounts for 20 per cent of all cases of heart failure-which opens the door to potential new treatments that could help counter the threat.

Read more Medical News

› Verified 5 days ago